- Home
- CTNT vs PPBT Comparison
CTNT vs PPBT Comparison
Compare CTNT & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- PPBT
- Stock Information
- Founded
- CTNT 2016
- PPBT 2010
- Country
- CTNT United States
- PPBT Israel
- Employees
- CTNT N/A
- PPBT N/A
- Industry
- CTNT
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- PPBT Health Care
- Exchange
- CTNT Nasdaq
- PPBT Nasdaq
- Market Cap
- CTNT 6.1M
- PPBT 5.5M
- IPO Year
- CTNT 2023
- PPBT N/A
- Fundamental
- Price
- CTNT $1.77
- PPBT $0.59
- Analyst Decision
- CTNT
- PPBT Strong Buy
- Analyst Count
- CTNT 0
- PPBT 1
- Target Price
- CTNT N/A
- PPBT $33.00
- AVG Volume (30 Days)
- CTNT 20.1K
- PPBT 234.5K
- Earning Date
- CTNT 11-12-2025
- PPBT 11-14-2025
- Dividend Yield
- CTNT N/A
- PPBT N/A
- EPS Growth
- CTNT N/A
- PPBT N/A
- EPS
- CTNT N/A
- PPBT N/A
- Revenue
- CTNT $1,119,333.00
- PPBT N/A
- Revenue This Year
- CTNT $302.80
- PPBT N/A
- Revenue Next Year
- CTNT $22.22
- PPBT N/A
- P/E Ratio
- CTNT N/A
- PPBT N/A
- Revenue Growth
- CTNT N/A
- PPBT N/A
- 52 Week Low
- CTNT $1.12
- PPBT $0.53
- 52 Week High
- CTNT $8.50
- PPBT $13.95
- Technical
- Relative Strength Index (RSI)
- CTNT 49.04
- PPBT 29.54
- Support Level
- CTNT $1.66
- PPBT $0.56
- Resistance Level
- CTNT $1.80
- PPBT $0.66
- Average True Range (ATR)
- CTNT 0.09
- PPBT 0.04
- MACD
- CTNT -0.01
- PPBT 0.05
- Stochastic Oscillator
- CTNT 43.85
- PPBT 29.11
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.